        id.exposure   id.outcome                                            outcome
1 met-d-bOHbutyrate finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
2 met-d-bOHbutyrate finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
3 met-d-bOHbutyrate finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
4 met-d-bOHbutyrate finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
5 met-d-bOHbutyrate finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
                                   exposure                    method nsnp           b
1 3-Hydroxybutyrate || id:met-d-bOHbutyrate                  MR Egger   14 -1.48882996
2 3-Hydroxybutyrate || id:met-d-bOHbutyrate           Weighted median   14 -0.28788637
3 3-Hydroxybutyrate || id:met-d-bOHbutyrate Inverse variance weighted   14  0.05506124
4 3-Hydroxybutyrate || id:met-d-bOHbutyrate               Simple mode   14 -0.48499089
5 3-Hydroxybutyrate || id:met-d-bOHbutyrate             Weighted mode   14 -0.43972595
         se      pval
1 0.9657129 0.1490963
2 0.4744851 0.5440273
3 0.3503961 0.8751345
4 0.6930709 0.4964022
5 0.5872402 0.4673101
